MA56505A - Inhibiteurs macrocycliques de mcl-1 - Google Patents
Inhibiteurs macrocycliques de mcl-1Info
- Publication number
- MA56505A MA56505A MA056505A MA56505A MA56505A MA 56505 A MA56505 A MA 56505A MA 056505 A MA056505 A MA 056505A MA 56505 A MA56505 A MA 56505A MA 56505 A MA56505 A MA 56505A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitors
- mcl
- macrocyclic
- macrocyclic mcl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19181605 | 2019-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56505A true MA56505A (fr) | 2022-04-27 |
Family
ID=67001598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056505A MA56505A (fr) | 2019-06-21 | 2020-06-18 | Inhibiteurs macrocycliques de mcl-1 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220306653A1 (fr) |
| EP (1) | EP3986902B1 (fr) |
| JP (1) | JP2022537393A (fr) |
| KR (1) | KR20220024694A (fr) |
| CN (1) | CN114641481A (fr) |
| AU (1) | AU2020296918A1 (fr) |
| BR (1) | BR112021025732A2 (fr) |
| CA (1) | CA3143613A1 (fr) |
| ES (1) | ES2975083T3 (fr) |
| MA (1) | MA56505A (fr) |
| MX (1) | MX2021015770A (fr) |
| WO (1) | WO2020254471A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019347963A1 (en) * | 2018-09-30 | 2021-05-27 | Jiangsu Hengrui Medicine Co., Ltd. | Indole macrocyclic derivative, preparation method therefor and application thereof in medicine |
| US11691989B2 (en) | 2018-11-22 | 2023-07-04 | Ascentage Pharma (Suzhou) Co., Ltd. | Macrocyclic indoles as Mcl-1 inhibitors |
| CN115151551A (zh) * | 2020-02-21 | 2022-10-04 | 詹森药业有限公司 | 作为mcl-1抑制剂的大环吲哚衍生物 |
| KR20230145079A (ko) * | 2021-02-12 | 2023-10-17 | 얀센 파마슈티카 엔브이 | 암의 치료를 위한 mcl-1 억제제로서의 마크로사이클릭1,3-브릿지된 6-클로로-7-피라졸-4-일-1h-인돌-2-카르복실레이트 및 6-클로로-7-피리미딘-5-일-1h-인돌-2-카르복실레이트 유도체 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3636649T (pt) * | 2014-01-24 | 2024-04-09 | Turning Point Therapeutics Inc | Diaril macrociclos como moduladores das proteínas quinases |
| JO3474B1 (ar) * | 2014-08-29 | 2020-07-05 | Amgen Inc | مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1 |
| KR102388208B1 (ko) | 2016-04-22 | 2022-04-18 | 아스트라제네카 아베 | 암을 치료하기 위한 거대 환형 mcl1 억제제 |
| TW201904976A (zh) | 2017-03-31 | 2019-02-01 | 瑞典商阿斯特捷利康公司 | Ｍｃｌ-１抑制劑及其使用方法 |
| TWI781996B (zh) | 2017-03-31 | 2022-11-01 | 瑞典商阿斯特捷利康公司 | 合成ｍｃｌ-１抑制劑之方法 |
| JP2020531457A (ja) * | 2017-08-15 | 2020-11-05 | アッヴィ・インコーポレイテッド | 大環状ｍｃｌ−１阻害剤及び使用の方法 |
| AU2019347963A1 (en) | 2018-09-30 | 2021-05-27 | Jiangsu Hengrui Medicine Co., Ltd. | Indole macrocyclic derivative, preparation method therefor and application thereof in medicine |
| US11691989B2 (en) * | 2018-11-22 | 2023-07-04 | Ascentage Pharma (Suzhou) Co., Ltd. | Macrocyclic indoles as Mcl-1 inhibitors |
-
2020
- 2020-06-18 KR KR1020227001787A patent/KR20220024694A/ko active Search and Examination
- 2020-06-18 MX MX2021015770A patent/MX2021015770A/es unknown
- 2020-06-18 MA MA056505A patent/MA56505A/fr unknown
- 2020-06-18 ES ES20734336T patent/ES2975083T3/es active Active
- 2020-06-18 JP JP2021575909A patent/JP2022537393A/ja active Pending
- 2020-06-18 CA CA3143613A patent/CA3143613A1/fr active Pending
- 2020-06-18 EP EP20734336.9A patent/EP3986902B1/fr active Active
- 2020-06-18 CN CN202080059643.7A patent/CN114641481A/zh active Pending
- 2020-06-18 WO PCT/EP2020/066890 patent/WO2020254471A1/fr active Application Filing
- 2020-06-18 BR BR112021025732A patent/BR112021025732A2/pt unknown
- 2020-06-18 AU AU2020296918A patent/AU2020296918A1/en active Pending
- 2020-06-18 US US17/618,995 patent/US20220306653A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN114641481A (zh) | 2022-06-17 |
| CA3143613A1 (fr) | 2020-12-24 |
| EP3986902A1 (fr) | 2022-04-27 |
| JP2022537393A (ja) | 2022-08-25 |
| ES2975083T3 (es) | 2024-07-03 |
| WO2020254471A1 (fr) | 2020-12-24 |
| EP3986902B1 (fr) | 2024-01-24 |
| KR20220024694A (ko) | 2022-03-03 |
| US20220306653A1 (en) | 2022-09-29 |
| BR112021025732A2 (pt) | 2022-04-12 |
| MX2021015770A (es) | 2022-04-12 |
| AU2020296918A1 (en) | 2022-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| IL291430A (en) | mcl–1 inhibitors | |
| MA52413A (fr) | Inhibiteurs de cd73 | |
| MA52812A (fr) | Inhibiteurs de sarm1 | |
| DK3687999T3 (da) | Rapamycinderivater | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| DK3783000T3 (da) | Makrocyklisk kinasehæmmer | |
| ES2975083T3 (es) | Inhibidores macrocíclicos de MCL-1 | |
| MA52809A (fr) | Inhibiteurs de sarm1 | |
| DK3768669T3 (da) | Piperazinazaspiroderivater | |
| AR120804A1 (es) | Derivados de isoxazolina | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| MA51611A (fr) | Inhibiteurs de pi4kiiibêta | |
| DK3738452T3 (da) | Fordamper | |
| DK3796975T3 (da) | Sulfonylaminobenzamidderivater | |
| DK3770162T3 (da) | Dihydrochromenderivater | |
| ES1243687Y (es) | Salmorejo | |
| IT201900020430A1 (it) | Espositore | |
| DE202019004111U8 (de) | Weichenstellvorichtung | |
| TH190914S (th) | ขันโตก | |
| TH190910S (th) | ขันโตก | |
| TH190911S (th) | ขันโตก | |
| DK3786413T3 (da) | Rullejalousi | |
| ES1235736Y (es) | Alcoholimetro |